Citations for
1HRASLS2, PLA2G16, RARRES3
Characterization of the human tumor suppressors TIG3 and HRASLS2 as phospholipid-metabolizing enzymes.
Uyama T, Jin XH, Tsuboi K, Tonai T, Ueda N.
Biochim Biophys Acta 1791(12):1114-24. Epub 2009 Jul 14.PMID: 19615464 2009
2RARRES3
Retinoic acid-induced gene-1 (RIG-I) associates with the actin cytoskeleton via caspase activation and recruitment domain-dependent interactions.
Mukherjee A, Morosky SA, Shen L, Weber CR, Turner JR, Kim KS, Wang T, Coyne CB.
J Biol Chem 284(10):6486-94. Epub 2009 Jan 3.PMID: 19122199 2009
3RARRES3
Essential role of the N-terminal domain in the regulation of RIG-I ATPase activity.
Gee P, Chua PK, Gevorkyan J, Klumpp K, Najera I, Swinney DC, Deval J.
J Biol Chem 283(14):9488-96. Epub 2008 Feb 11. 2008
4RARRES3
RIG-I plays a critical role in negatively regulating granulocytic proliferation.
Zhang NN, Shen SH, Jiang LJ, Zhang W, Zhang HX, Sun YP, Li XY, Huang QH, Ge BX, Chen SJ, Wang ZG, Chen Z, Zhu J.
Proc Natl Acad Sci U S A 105(30):10553-8. Epub 2008 Jul 23. 2008
5CYLD, RARRES3
The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.
Friedman CS, O'Donnell MA, Legarda-Addison D, Ng A, Cárdenas WB, Yount JS, Moran TM, Basler CF, Komuro A, Horvath CM, Xavier R, Ting AT.
EMBO Rep 9(9):930-6. Epub 2008 Jul 18. 2008
6CASP1, RARRES3
Active caspase-1-mediated secretion of retinoic acid inducible gene-I.
Kim MJ, Yoo JY.
J Immunol 181(10):7324-31.PMID: 18981155 2008
7RARRES3
Localization of the TIG3 transglutaminase interaction domain and demonstration that the amino-terminal region is required for TIG3 function as a keratinocyte differentiation regulator.
Jans R, Sturniolo MT, Eckert RL.
J Invest Dermatol 128(3):517-29. Epub 2007 Aug 30.PMID: 17762858 2008
8RARRES3, RNF125
Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125.
Arimoto K, Takahashi H, Hishiki T, Konishi H, Fujita T, Shimotohno K.
Proc Natl Acad Sci U S A 104(18):7500-5. Epub 2007 Apr 25. 2007
9RARRES1, RARRES3
Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.
Kwong J, Lo KW, Chow LS, Chan FL, To KF, Huang DP.
Int J Cancer 113(3):386-92. 2005
10RARRES3
Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype.
Higuchi E, Chandraratna RA, Hong WK, Lotan R.
Oncogene 22(30):4627-35. 2003
11RARRES3
Cloning and characterization of a novel retinoid-inducible gene 1(RIG1) deriving from human gastric cancer cells.
Huang SL, Shyu RY, Yeh MY, Jiang SY.
Mol Cell Endocrinol 159(1-2):15-24. 2000